Recurrent hepatocellular carcinoma with rapid growth after cardiac surgery

Hepato-Gastroenterology

Volumn 52, Issue 66, 2005, Pages 1863-1866

  Shimizu, Hideyuki ^a   Katano, Yoshiaki ^a   Nagano, Kenichi ^a   Yokozaki, Shoichi ^a   Shimizu, Fukiko ^a   Naito, Takehito ^a   Hayashi, Kazuhiko ^a   Shimizu, Yuko ^a   Honda, Takashi ^a   Kaneko, Tetsuya ^a   Akita, Shinji ^b   Nakano, Isao ^a   Fukuda, Yoshihide ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Gifu Prefectural Tajimi Hospital   (Japan)

Author keywords

Cardiac surgery; Hepatocellular carcinoma; Recurrence

Indexed keywords

AGED; ARTICLE; CANCER GROWTH; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EXTRACORPOREAL CIRCULATION; FOLLOW UP; HEART DISEASE; HEART SURGERY; HEART VALVE REPLACEMENT; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MALE; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT CANCER; VALVULAR HEART DISEASE;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE PROGRESSION; FATAL OUTCOME; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HEPATITIS C, CHRONIC; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL;

EID: 28544447613     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS: Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210:655-661.
2. Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H, Kosuge T: Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34:707-713.
3. Eskola J, Salo M, Viljanen MK, Ruuskanen O: Impaired B lymphocyte function during open-heart surgery. Effects of anaesthesia and surgery. Br J Anaesth 1984; 56:333-338.
4. Ryhanen P, Huttunen K, Ilonen J: Natural killer cell activity after open-heart surgery. Acta Anaesthesiol Scand 1984; 28:490-492.
5. Burrows L, Tartter P: Effect of blood transfusions on colonic malignancy recurrent rate. Lancet 1982; 2:662.
6. Canver CC, Marrin CA, Plume SK, Nugent WC: Should a patient with a treated cancer be offered an open heart operation? Ann Thorac Surg 1993; 55:1202-1204.
7. Weintraub RM: Selection of patients coronary artery surgery. In: Grillo HC, Austen WG, Wilkins EW, Mathisen DJ, Vlahakes GJ (Eds.). Current therapy in cardiothoracic surgery. Toronto: B.C. Decker, 1989; pp. 408-411.
8. Kubo S, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Ikebe T, Yamamoto T, Wakasa K, Nishiguchi S, Kuroki T, Kinoshita H: Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. World J Surg 2000; 24:1559-1565.
9. Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS: Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol 2002; 8:237-242.
10. Peters RM, Swain JA: Management of the patient with emphysema, coronary artery disease, and lung cancer. Am J Surg 1982; 143:701-705.
11. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD: Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86:845-857.
12. Takahashi T, Nakano S, Shimazaki Y, Kaneko M, Nakahara K, Miyata M, Kamiike W, Matsuda H: Concomitant coronary bypass grafting and curative surgery for cancer. Surg Today 1995; 25:131-135.
13. Ochi M, Yamada K, Fujii M, Ohkubo N, Ogasawara H, Tanaka S: Role of off-pump coronary artery bypass grafting in patients with malignant neoplastic disease. Jpn Circ J 2000; 64:13-17.
14. Chuang WL, Liu HW, Chang WY: Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion. Cancer 1990; 65:926-930.
15. Ono K, Yamanaga Y, Yamamoto K, Koga SI, Nishimura J, Nawata H: Natural killing activities in chronic liver diseases and hepatocellular carcinoma. J Clin Immunol 1996; 16:41-45.
16. Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Chayama K, Murashima N, Kumada H: Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000; 32:228-232.
17. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Yamazaki O, Shiomi S, Tamori A, Oka H, Igawa S, Kuroki T, Kinoshita H: Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med 2001; 134:963-967.